Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Radiation vs Chemoradiation in Node-Positive Vulvar Cancer
NCT00006096Phase 3Terminated
- Sponsor
- GOG Foundation
- Start
- Mar 2001
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of cisplatin in vulvar cancer (2 arms), sponsored by GOG Foundation. Primary endpoints: Recurrence-Free Interval and Overall Survival. Started Mar 2001; status: terminated.
02
Drugs
cisplatin
03
Conditions
vulvar cancer
Beyond the preview
Go deeper on NCT00006096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006096.